secwatch.observer — SEC 8-K summary
======================================

Issuer:     RxSight, Inc. (RXST)
CIK:        0001111485
Form:       8-K
Filed at:   2022-12-12T23:59:59+00:00
Accession:  0000950170-22-026362
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RxSight amends bylaws to update director nomination procedures and conform to Delaware law
--------------------------------------------------------------------------------

- Amended bylaws require stockholders nominating directors to provide evidence of compliance with Rule 14a-19 at least five business days before meeting.
- Revised stockholder meeting procedures and board action by written consent to conform to recent DGCL amendments.
- Updated provisions regarding directors, Board committees, and officers; made ministerial and conforming changes.
- Bylaw amendments effective December 9, 2022, approved by Board on recommendation of Corporate Governance and Nominating Committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1111485/000095017022026362/0000950170-22-026362-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1111485/000095017022026362/rxst-20221209.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-026362

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer